Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, ...

(Denver, Colo—October 6, 2025) Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due ...

As next-generation antibody-drug conjugates reshape cancer care, digital pathology and artificial intelligence are transforming how HER2 is measured. The advances aim to help clinicians identify low ...

USC doctors say careful staging and tumor testing help younger patients choose surgery and targeted treatments based on their ...

A key outcome from lung cancer screening studies is the concept of ‘stage-shift’ seen in screen-detected cancers compared ...

The first-in-human case was performed using the LIA™ system's integrated optical imaging, which provides real-time, ...

An international team confirms in a pioneering phase 3 clinical trial the decisive role of the time of day on the success of anti-tumour immunotherapies. Huang, Z., Zeng, L., Ruan, Z. et al.

Pathology has long been the cornerstone of cancer diagnosis and treatment. A pathologist carefully examines an ultrathin slice of human tissue under a microscope for clues that indicate the presence, ...

AI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research shows these systems can infer patient demographics from pathology slides, ...

Lung cancer is one of the leading causes of cancer-related death in our country, especially due to widespread myths and the lack of awareness.